Suppr超能文献

心脏再同步治疗对逆重构的影响及其与预后的关系:多中心自动除颤器植入试验:心脏再同步治疗。

Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.

机构信息

Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

出版信息

Circulation. 2010 Sep 7;122(10):985-92. doi: 10.1161/CIRCULATIONAHA.110.955039. Epub 2010 Aug 23.

Abstract

BACKGROUND

Cardiac resynchronization therapy (CRT) plus implantation of an implantable cardioverter defibrillator (ICD) reduced the risk of death or heart failure event in patients with mildly symptomatic heart failure, left ventricular dysfunction, and wide QRS complex compared with an ICD only. We assessed echocardiographic changes in patients enrolled in the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy) to evaluate whether the improvement in outcomes with CRT plus an ICD was associated with favorable alterations in cardiac size and function.

METHODS AND RESULTS

A total of 1,820 patients were randomly assigned to CRT plus an ICD or to an ICD only in a 3:2 ratio. Echocardiographic studies were obtained at baseline and 12 months later in 1,372 patients. We compared changes in cardiac size and performance between treatment groups and assessed the relationship between these changes over the first year, as well as subsequent outcomes. Compared with the ICD-only group, the CRT-plus-ICD group had greater improvement in left ventricular end-diastolic volume index (-26.2 versus -7.4 mL/m(2)), left ventricular end-systolic volume index (-28.7 versus -9.1 mL/m(2)), left ventricular ejection fraction (11% versus 3%), left atrial volume index (-11.9 versus -4.7 mL/m(2)), and right ventricular fractional area change (8% versus 5%; P<0.001 for all). Improvement in end-diastolic volume at 1 year was predictive of subsequent death or heart failure, with adjustment for baseline covariates and treatment group; each 10% decrease in end-diastolic volume was associated with a 40% reduction in risk (P<0.001).

CONCLUSIONS

CRT resulted in significant improvement in cardiac size and performance compared with an ICD-only strategy in patients with mildly symptomatic heart failure. Improvement in these measures accounted for the outcomes benefit. Clinical Trial Registration Information- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00180271.

摘要

背景

与单独植入植入式心脏复律除颤器(ICD)相比,心脏再同步治疗(CRT)加植入 ICD 可降低轻度症状性心力衰竭、左心室功能障碍和宽 QRS 复合物患者的死亡或心力衰竭事件风险。我们评估了 MADIT-CRT 试验(多中心自动除颤器植入试验:心脏再同步治疗)中入组患者的超声心动图变化,以评估 CRT 加 ICD 的改善是否与心脏大小和功能的有利改变相关。

方法和结果

总共 1820 名患者以 3:2 的比例随机分配到 CRT 加 ICD 组或仅 ICD 组。1372 名患者在基线和 12 个月时获得超声心动图研究。我们比较了两组之间心脏大小和功能的变化,并评估了第一年这些变化之间的关系以及随后的结果。与仅 ICD 组相比,CRT 加 ICD 组左心室舒张末期容积指数改善更大(-26.2 比-7.4 mL/m²),左心室收缩末期容积指数改善更大(-28.7 比-9.1 mL/m²),左心室射血分数改善更大(11%比 3%),左心房容积指数改善更大(-11.9 比-4.7 mL/m²),右心室面积分数变化改善更大(8%比 5%;所有 P<0.001)。第 1 年舒张末期容积的改善可预测随后的死亡或心力衰竭,调整了基线协变量和治疗组;舒张末期容积每降低 10%,风险降低 40%(P<0.001)。

结论

与单独 ICD 策略相比,CRT 可使轻度症状性心力衰竭患者的心脏大小和功能显著改善。这些措施的改善解释了治疗结果的获益。临床试验注册信息- URL:http://www.clinicaltrials.gov。独特标识符:NCT00180271。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验